Viridian Therapeutics slides on pricing $225M securities offering Source: Seekingalpha
Browsing: Viridian
Viridian hits five-month high after trial data for lead asset (replace) Source: Seekingalpha
Viridian Therapeutics announces proposed underwritten offering Source: Seekingalpha
Viridian hits five-month high after trial data for lead asset (replace) Source: Seekingalpha
Viridian Therapeutics announces proposed underwritten offering Source: Seekingalpha
magicmine/iStock by way of Getty Images Update 3.15 PM EST: Adds newest share worth transfer and feedback from BTIG Viridian Therapeutics (NASDAQ:VRDN) added ~26% to succeed…
Viridian posts initial late-stage trial data for lead asset Source: Seekingalpha